Westat Inc., Rockville, Maryland, was awarded a $12,136,555 cost-plus-fixed-fee contract with options to develop and license valproic acid for the treatment of patients with significant hemorrhage. Work will be performed in Rockville, Maryland, with an estimated completion date of Sept. 13, 2018. Bids were solicited via the Internet with one received. Fiscal 2014 research, development, testing, and evaluation funds in the amount of $12,136,555 were obligated at the time of the award. Army Medical Research Acquisition Activity, Frederick, Maryland, is the contracting activity (W81XWH-15-C-0128).
-- You received this message because you are subscribed to the Google Groups "massfire" group. To unsubscribe from this group and stop receiving emails from it, send an email to [email protected]. To post to this group, send email to [email protected]. Visit this group at http://groups.google.com/group/massfire. For more options, visit https://groups.google.com/d/optout.
